Related Concepts
Related Feeds
AML: Role of LSD1 by CRISPR (Keystone)
Find the latest rersearrch on the ability of CRISPR-Cas9 mutagenesis to profile the interactions between lysine-specific histone demethylase 1 (LSD1) and chemical inhibitors in the context of acute myeloid leukemia (AML) here.
Acute Myeloid Leukemia
Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.
Related Papers
Leukemia
Akihiro TsuboiH Sugiyama
Pediatric Hematology and Oncology
Shao-Yan HuChien-Shing Chen
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
Daniela CilloniDavid Grimwade
American Journal of Hematology
Gunter KerstIngo Müller
Zhongguo shi yan xue ye xue za zhi
Bo BaiZhen-Hua Qiao